Background : In stage II rectal cancer, it has remained controversial whether patients get the benefit from adjuvant treatment after curative resection. The aim of this study is to evaluate the prognostic factors of stage II rectal cancer. Methods : From October 2000 to December 2008, 200 patients with stage II rectal cancer underwent surgery at National Cancer Center. Univariate and multivariate survival analyses were performed to determine the prognostic factors in stage II rectal cancer.Results : In stage II rectal cancer, 5-year overall survival and disease free survival were 89.2% and 89.0%, respectively. For overall survival, there was no significant prognostic factor in multivariable analysis. For diseasefree survival, tumor differentiation and circumferential resection margin were significant prognostic factors in multivariable analysis.Conclusion : Tumor differentiation and circumference resection margin are independent prognostic factors in disease free survival of stage II rectal cancer. Adjuvant treatment may be considered in patients with these factors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.